Study to Evaluate the Safety of Albuterol in a Dry Powder Inhaler

- Asthma
- Terminated

Study Title: A Twelve Month Long Term Safety Study to Evaluate the Safety of Albuterol in a Dry Powder Inhaler With Both Repeated and as Needed Dosing

Teva Identifier: ABS-AS-306

ClinicalTrials.gov Identifier: NCT01218009

Study Status: Terminated

Trial Condition(s): Asthma

Interventions: Drug: Placebo Spiromax | Drug: Albuterol Spiromax

Study Description

Please refer to ClinicalTrials.gov for a description of the trial

Participation criteria and map of study locations

Key Participation Requirements

Gender: Female, Male

Age group: Child, Adult, Older Adult

Age Range: 12 Years and older

Trial Duration: 10/01/2010 - 12/01/2010

Phase: Phase 3

Study Type

Interventional